Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 5/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9915355 | 0.77 | COMT (0.38) | KMT2ARAB9ANPC1TDP1L3MBTL1 | |
| SCHEMBL9915322 | 0.77 | CYP1A2 (0.34) | KMT2ARAB9AHPGDTSHRNPC1 | |
| SCHEMBL16748752 | 0.77 | TP53 (0.34) | KMT2ARAB9AHPGDTSHRNPC1 | |
| SCHEMBL16748757 | 0.75 | S1PR2 (0.33) | KMT2ARAB9ATSHRNPC1TDP1 | |
| SCHEMBL9172410 | 0.73 | CASP3 (0.51) | KMT2ARAB9A | |
| SCHEMBL9915356 | 0.72 | MEN1 (0.33) | KMT2ARAB9ANPC1L3MBTL1MAPT | |
| SCHEMBL9915436 | 0.71 | FAAH (0.36) | TSHRMAPK1RECQLALDH1A1 | |
| SCHEMBL9915312 | 0.71 | ALDH1A1 (0.47) | KMT2ARAB9AHPGDTSHRNPC1 | |
| SCHEMBL15279057 | 0.70 | TP53 (0.33) | KMT2AHPGDTSHRTDP1MAPK1 | |
| SCHEMBL9915301 | 0.70 | TDP1 (0.36) | KMT2ARAB9ANPC1TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150148326-A1 | Monobactams | PFIZER (US) | 2015-05-28 | — | — | US | disclosed |
| US-20130252935-A1 | Monobactams | PFIZER INC. (US) | 2013-09-26 | — | — | US | disclosed |
| US-20120302542-A1 | MONOBACTAMS | PFIZER INC | 2012-11-29 | — | — | US | disclosed |
| WO-2012073138-A1 | MONOBACTAMS | PFIZER INC. (US) | 2012-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130252935-A1 | Monobactams | MGAM, MGAM2, BPGM | KMT2A 608/4885RAB9A 2614/4885HPGD 2345/4885 |
| US-20150148326-A1 | Monobactams | MGAM, MGAM2, BPGM | KMT2A 608/4885RAB9A 2614/4885HPGD 2345/4885 |
| US-20120302542-A1 | MONOBACTAMS | MGAM, MGAM2, BPGM | KMT2A 608/4885RAB9A 2614/4885HPGD 2345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.